|
1
|
Abdellah A, Selma K, Elamin M, Asmae T,
Lamia R, Abderrahmane M, Sanaa el M, Hanan E, Tayeb K and
Noureddine B: Renal cell carcinoma in children: Case report and
literature review. Pan Afr Med J. 20:842015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kostrzewa M, Zyła M, Władziński J,
Stetkiewicz T, Stachowiak G and Wilczyński JR: Metastases of renal
clear cell carcinoma to ovary-case report and review of the
literature. Eur J Gynaecol Oncol. 36:219–222. 2015.
|
|
3
|
Ye DW and Zhang HL: Critical appraisal of
sorafenib in the treatment of Chinese patients with renal cell
carcinoma. Onco Targets Ther. 7:925–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chow TF, Youssef YM, Lianidou E, Romaschin
AD, Honey RJ, Stewart R, Pace KT and Yousef GM: Differential
expression profiling of microRNAs and their potential involvement
in renal cell carcinoma pathogenesis. Clin Biochem. 43:150–158.
2010. View Article : Google Scholar
|
|
6
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
7
|
Lim LP, Glasner ME, Yekta S, Burge CB and
Bartel DP: Vertebrate microRNA genes. Science. 299:15402003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsushima K, Isomoto H, Yamaguchi N,
Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S,
Nagayasu T, et al: MiRNA-205 modulates cellular invasion and
migration via regulating zinc finger E-box binding homeobox 2
expression in esophageal squamous cell carcinoma cells. J Transl
Med. 9:302011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gandellini P, Folini M, Longoni N, Pennati
M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta
P, et al: miR-205 Exerts tumor-suppressive functions in human
prostate through down-regulation of protein kinase Cepsilon. Cancer
Res. 69:2287–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:658–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Majid S, Saini S, Dar AA, Hirata H,
Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, et
al: MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal
cancer. Cancer Res. 71:2611–2621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Fan Y, Chen W, Huang Q, Ai Q, Ni D,
Ma X and Zhang X: Effect of E2Fl knockdown on proliferation and
invasion of clear cell renal cell carcinoma cell line Caki-2. Zhong
Hua Shi Yan Wai Ke Za Zhi She. 333–335. 2013.In Chinese.
|
|
13
|
Li Y, Zhang J, Ge D, Yang Y and Yu J:
Expression and significance of E-cadherin and Bcl-2 in early renal
carcinoma and adjacent tissues of different levels of distance. J
Contemp Urol Reprod Onco. 108–111. 2011.In Chinese.
|
|
14
|
Dar AA, Majid S, de Semir D, Nosrati M,
Bezrookove V and Kashani-Sabet M: miRNA-205 suppresses melanoma
cell proliferation and induces senescence via regulation of E2F1
protein. J Biol Chem. 286:16606–16614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Piovan C, Palmieri D, Di Leva G, Braccioli
L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi
T, et al: Oncosuppressive role of p53-induced miR-205 in triple
negative breast cancer. Mol Oncol. 6:458–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang JD, Nakamura I and Roberts LR: The
tumor microenvironment in hepatocellular carcinoma: Current status
and therapeutic targets. Semin Cancer Biol. 21:35–43. 2011.
View Article : Google Scholar :
|
|
17
|
Ogunwobi OO and Liu C: Therapeutic and
prognostic importance of epithelial-mesenchymal transition in liver
cancers: Insights from experimental models. Crit Rev Oncol Hematol.
83:319–328. 2012. View Article : Google Scholar
|
|
18
|
Yamada S, Okumura N, Wei L, Fuchs BC,
Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK and Kodera Y:
Epithelial to mesenchymal transition is associated with shorter
disease-free survival in hepatocellular carcinoma. Ann Surg Oncol.
21:3882–3890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou KZ, Fu ZQ and Gong H: Chemokine ligand
20 enhances progression of hepatocellular carcinoma via
epithelial-mesenchymal transition. World J Gastroenterol.
21:475–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang Y, Wei J, Cao J, Zhao H, Liao B, Qiu
S, Wang D, Luo J and Chen W: Protein expression of ZEB2 in renal
cell carcinoma and its prognostic significance in patient survival.
PLoS One. 8:e625582013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger
B, Guo J and Xu X: Loss of microRNA-205 expression is associated
with melanoma progression. Lab Invest. 92:1084–1096. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hager M, Haufe H, Lusuardi L, Schmeller N
and Kolbitsch C: PTEN, pAKT, and pmTOR expression and subcellular
distribution in primary renal cell carcinomas and their metastases.
Cancer Invest. 29:427–438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang G, Hou X, Li Y and Zhao M: MiR-205
inhibits cell apoptosis by targeting phosphatase and tensin homolog
deleted on chromosome ten in endometrial cancer Ishikawa cells. BMC
Cancer. 14:4402014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai J, Fang L, Huang Y, Li R, Yuan J, Yang
Y, Zhu X, Chen B, Wu J and Li M: miR-205 targets PTEN and PHLPP2 to
augment AKT signaling and drive malignant phenotypes in non-small
cell lung cancer. Cancer Res. 73:5402–5415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang
S, Wang X, Zhang R, Lee MH and Yang H: MiR-205 determines the
radioresistance of human nasopharyngeal carcinoma by directly
targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
